Leichner PK - Search Results

1

Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49.

Leichner PK, Akabani G, Colcher D, Harrison KA, Hawkins WG, Eckblade M, Baranowska-Kortylewicz J, Augustine SC, Wisecarver J, Tempero MA. Leichner PK, et al. J Nucl Med. 1997 Apr;38(4):512-6. J Nucl Med. 1997. PMID: 9098192 Free article.

2

Antiidiotypic response against murine monoclonal antibodies reactive with tumor-associated antigen TAG-72.

Blanco I, Kawatsu R, Harrison K, Leichner P, Augustine S, Baranowska-Kortylewicz J, Tempero M, Colcher D. Blanco I, et al. J Clin Immunol. 1997 Jan;17(1):96-106. doi: 10.1023/a:1027396714623. J Clin Immunol. 1997. PMID: 9049790

3

High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: a phase I trial.

Tempero M, Leichner P, Dalrymple G, Harrison K, Augustine S, Schlam J, Anderson J, Wisecarver J, Colcher D. Tempero M, et al. J Clin Oncol. 1997 Apr;15(4):1518-28. doi: 10.1200/JCO.1997.15.4.1518. J Clin Oncol. 1997. PMID: 9193348 Clinical Trial.

4

High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial.

Tempero M, Leichner P, Baranowska-Kortylewicz J, Harrison K, Augustine S, Schlom J, Anderson J, Wisecarver J, Colcher D. Tempero M, et al. Clin Cancer Res. 2000 Aug;6(8):3095-102. Clin Cancer Res. 2000. PMID: 10955789 Clinical Trial.

5

Patient-specific dosimetry using quantitative SPECT imaging and three-dimensional discrete Fourier transform convolution.

Akabani G, Hawkins WG, Eckblade MB, Leichner PK. Akabani G, et al. Among authors: leichner pk. J Nucl Med. 1997 Feb;38(2):308-14. J Nucl Med. 1997. PMID: 9025760 Free article.

6

SPECT imaging of fluorine-18.

Leichner PK, Morgan HT, Holdeman KP, Harrison KA, Valentino F, Lexa R, Kelly RF, Hawkins WG, Dalrymple GV. Leichner PK, et al. J Nucl Med. 1995 Aug;36(8):1472-5. J Nucl Med. 1995. PMID: 7629597 Free article.

7

Radiolabeled iododeoxyuridine: safety evaluation.

Harrison KA, Dalrymple GV, Baranowska-Kortylewicz J, Holdeman KP, Schneiderman MH, Lieberman RP, Sharp JG, Cohen SM, Leichner PK, Augustine SC, Tempero MA, Taylor RJ, Chiou RK. Harrison KA, et al. Among authors: leichner pk. J Nucl Med. 1996 Apr;37(4 Suppl):13S-16S. J Nucl Med. 1996. PMID: 8676196

8

Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma.

Vose JM, Colcher D, Gobar L, Bierman PJ, Augustine S, Tempero M, Leichner P, Lynch JC, Goldenberg D, Armitage JO. Vose JM, et al. Leuk Lymphoma. 2000 Jun;38(1-2):91-101. doi: 10.3109/10428190009060322. Leuk Lymphoma. 2000. PMID: 10811451 Clinical Trial.

9

Quantitative SPECT for indium-111-labeled antibodies in the livers of beagle dogs.

Leichner PK, Vriesendorp HM, Hawkins WG, Quadri SM, Yang NC, Stinson RL, Loudenslager DM, Frankel TL, Chen XY, Klein JL. Leichner PK, et al. J Nucl Med. 1991 Jul;32(7):1442-4. J Nucl Med. 1991. PMID: 2066804 Free article.

10

Validation of the circular harmonic transform (CHT) algorithm for quantitative SPECT.

Hawkins WG, Yang NC, Leichner PK. Hawkins WG, et al. Among authors: leichner pk. J Nucl Med. 1991 Jan;32(1):141-50. J Nucl Med. 1991. PMID: 1988620 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page